With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Jonas Elmerraji is editor of the Rhino Stock Report, a GARP investment newsletter. He launched the "Young Investor" category for Investopedia. Andy Smith is a Certified Financial Planner (CFP®), ...

Trade imbalances can impact supply and demand and, in turn, exchange rates Hans Daniel Jasperson has over a decade of experience in public policy research, with an emphasis on workforce development, ...